United States In Vitro Fertilization Market Overview
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Growth Rate: 5.75% (2024-2032)
The United States in vitro fertilization market size is on the rise due to several key factors. One major contributor is the increasing occurrence of infertility among couples, linked to changing lifestyles, delayed parenthood, and underlying health conditions. According to the latest report by IMARC Group, the market is projected to grow at a CAGR of 5.75% from 2024 to 2032.
United States In Vitro Fertilization Industry Trends and Drivers:
As more people choose to start families later in life, the demand for fertility treatments, especially IVF, is steadily increasing. Moreover, advancements in reproductive technologies, such as preimplantation genetic testing and improved embryo transfer techniques, are improving the success rates of IVF procedures, boosting patient confidence, and propelling market growth. Insurance providers’ support, with a growing number of states requiring coverage for fertility treatments, is also making IVF more accessible to a wider population. The growing awareness and acceptance of assisted reproductive technologies (ART) among patients and healthcare providers are leading to an increase in IVF clinics and specialized fertility centers across the country. Furthermore, government regulations and substantial investments in reproductive medicine research and development are driving innovation, ensuring the U.S. remains a leader in the global IVF market.
The United States In Vitro Fertilization (IVF) market is experiencing significant trends driven by healthcare and technological advancements. Artificial intelligence (AI) and machine learning (ML) are increasingly utilized in IVF procedures to enhance embryo selection and improve success rates. AI-based models predict the likelihood of successful pregnancies, leading to personalized treatment plans. There is also a focus on minimally invasive procedures and advanced cryopreservation techniques, improving treatment efficiency. Natural and mild stimulation IVF protocols are gaining popularity for being safer and less invasive. Additionally, holistic approaches incorporating complementary therapies such as acupuncture and stress management programs are being integrated into fertility treatment. The COVID-19 pandemic has accelerated telemedicine adoption in fertility care, offering remote consultations and monitoring services. These trends indicate sustained growth and innovation in the United States IVF market, emphasizing technological advancements and patient-centered care.
United States In Vitro Fertilization Industry Segmentation:
The report has segmented the market into the following categories:
Product Insights:
- Reagent
- Cryopreservation Media
- Embryo Culture Media
- Ovum Processing Media
- Sperm Processing Media
- Instrument
- Imaging Systems
- Incubators
- Cryosystems
- IVF Cabinet
- Ovum Aspiration Pump
- Sperm Separation Systems
- Micromanipulator Systems
- Others
- Accessories
Procedure Type Insights:
- Fresh Donor
- Frozen Donor
- Fresh Non-donor
- Frozen Non-donor
Cycle Type Insights:
- Conventional IVF
- IVF with ICSI
- IVF with Donor Eggs
End User Insights:
- Fertility Clinics
- Hospitals
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=19063&flag=F
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145